Variant report
Variant | esv2762610 |
---|---|
Chromosome Location | chr17:18288994-18510158 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1427)
- CpG islands (count:1832)
- Chromatin interactive region (count:3)
- LncRNA region (count:91)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr17:18467518-18467720 | HepG2 | liver: | n/a | n/a |
2 | ATF2 | chr17:18314118-18314356 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | BACH1 | chr17:18362390-18362672 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | BACH1 | chr17:18472043-18472169 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | BACH1 | chr17:18355389-18355575 | H1-hESC | embryonic stem cell: | n/a | n/a |
6 | BATF | chr17:18496542-18496830 | GM12878 | blood: | n/a | n/a |
7 | BATF | chr17:18396335-18396562 | GM12878 | blood: | n/a | chr17:18396479-18396490 |
8 | BATF | chr17:18301531-18301764 | GM12878 | blood: | n/a | n/a |
9 | BATF | chr17:18509282-18509509 | GM12878 | blood: | n/a | n/a |
10 | BATF | chr17:18379801-18380128 | GM12878 | blood: | n/a | n/a |
11 | BATF | chr17:18411051-18411300 | GM12878 | blood: | n/a | chr17:18411156-18411166 chr17:18411155-18411166 |
12 | BATF | chr17:18306836-18307314 | GM12878 | blood: | n/a | n/a |
13 | BATF | chr17:18483436-18483734 | GM12878 | blood: | n/a | n/a |
14 | BATF | chr17:18396259-18396664 | GM12878 | blood: | n/a | chr17:18396479-18396490 |
15 | BATF | chr17:18379787-18380078 | GM12878 | blood: | n/a | n/a |
16 | BATF | chr17:18306799-18307466 | GM12878 | blood: | n/a | n/a |
17 | BATF | chr17:18509195-18509490 | GM12878 | blood: | n/a | n/a |
18 | BATF | chr17:18410950-18411370 | GM12878 | blood: | n/a | chr17:18411156-18411166 chr17:18411155-18411166 |
19 | BATF | chr17:18483425-18483804 | GM12878 | blood: | n/a | n/a |
20 | BATF | chr17:18467472-18467685 | GM12878 | blood: | n/a | n/a |
21 | BATF | chr17:18503769-18504272 | GM12878 | blood: | n/a | n/a |
22 | BCL11A | chr17:18424410-18424651 | GM12878 | blood: | n/a | n/a |
23 | BCL11A | chr17:18509267-18509452 | GM12878 | blood: | n/a | n/a |
24 | BCL11A | chr17:18379766-18380162 | GM12878 | blood: | n/a | n/a |
25 | BCL11A | chr17:18472933-18473174 | H1-hESC | embryonic stem cell: | n/a | n/a |
26 | BCL11A | chr17:18378052-18378384 | GM12878 | blood: | n/a | n/a |
27 | BCL11A | chr17:18472981-18473247 | H1-hESC | embryonic stem cell: | n/a | n/a |
28 | BCL11A | chr17:18483453-18483768 | GM12878 | blood: | n/a | n/a |
29 | BCL11A | chr17:18306911-18307191 | GM12878 | blood: | n/a | n/a |
30 | BCL11A | chr17:18379825-18380074 | GM12878 | blood: | n/a | n/a |
31 | BCL11A | chr17:18306873-18307246 | GM12878 | blood: | n/a | n/a |
32 | BCL11A | chr17:18503757-18504030 | GM12878 | blood: | n/a | n/a |
33 | BCL11A | chr17:18509177-18509596 | GM12878 | blood: | n/a | n/a |
34 | BCL3 | chr17:18314773-18315245 | A549 | lung: | n/a | n/a |
35 | BHLHE40 | chr17:18466647-18467016 | K562 | blood: | n/a | n/a |
36 | BHLHE40 | chr17:18396537-18396565 | K562 | blood: | n/a | n/a |
37 | BHLHE40 | chr17:18424672-18424862 | GM12878 | blood: | n/a | n/a |
38 | CEBPB | chr17:18322048-18322324 | K562 | blood: | n/a | n/a |
39 | CEBPB | chr17:18467516-18467710 | MCF-7 | breast: | n/a | n/a |
40 | CEBPB | chr17:18484451-18484641 | A549 | lung: | n/a | n/a |
41 | CEBPB | chr17:18467515-18467676 | HepG2 | liver: | n/a | n/a |
42 | CEBPB | chr17:18467487-18467735 | A549 | lung: | n/a | n/a |
43 | CEBPB | chr17:18509221-18509565 | K562 | blood: | n/a | n/a |
44 | CEBPB | chr17:18322055-18322251 | K562 | blood: | n/a | n/a |
45 | CEBPB | chr17:18322037-18322380 | K562 | blood: | n/a | n/a |
46 | CEBPB | chr17:18508664-18508935 | K562 | blood: | n/a | n/a |
47 | CEBPB | chr17:18318052-18318134 | A549 | lung: | n/a | chr17:18318100-18318113 chr17:18318102-18318113 chr17:18318102-18318111 |
48 | CEBPB | chr17:18509247-18509490 | K562 | blood: | n/a | n/a |
49 | CEBPB | chr17:18484454-18484578 | H1-hESC | embryonic stem cell: | n/a | n/a |
50 | CEBPB | chr17:18362356-18362662 | IMR90 | lung: | n/a | chr17:18362363-18362376 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:18476310-18476360 | AG09319 | gingival: | n/a |
2 | chr17:18313121-18313171 | HepG2 | liver: | n/a |
3 | chr17:18476310-18476360 | AG09319 | gingival: | n/a |
4 | chr17:18313121-18313171 | HepG2 | liver: | n/a |
5 | chr17:18476310-18476360 | HMEC | breast: | n/a |
6 | chr17:18317909-18317959 | HepG2 | liver: | n/a |
7 | chr17:18302510-18302560 | HCF | heart: | n/a |
8 | chr17:18429951-18430001 | SK-N-SH_RA | brain: | n/a |
9 | chr17:18291699-18291749 | Jurkat | blood: | n/a |
10 | chr17:18380354-18380404 | AG09319 | gingival: | n/a |
11 | chr17:18290668-18290718 | NT2-D1 | testis: | n/a |
12 | chr17:18476399-18476449 | AG09309 | skin: | n/a |
13 | chr17:18475978-18476028 | SK-N-MC | brain: | n/a |
14 | chr17:18428092-18428142 | HUVEC | blood vessel: | n/a |
15 | chr17:18295503-18295553 | LNCaP | prostate: | n/a |
16 | chr17:18290668-18290718 | AoSMC | blood vessel: | n/a |
17 | chr17:18428092-18428142 | NHBE | bronchial: | n/a |
18 | chr17:18431043-18431093 | AG09319 | gingival: | n/a |
19 | chr17:18324895-18324945 | ovcar-3 | ovarian: | n/a |
20 | chr17:18295503-18295553 | HL-60 | blood: | n/a |
21 | chr17:18476310-18476360 | AG10803 | skin: | n/a |
22 | chr17:18325001-18325051 | NHDF-neo | bronchial: | n/a |
23 | chr17:18378879-18378929 | NH-A | brain: | n/a |
24 | chr17:18378879-18378929 | AG10803 | skin: | n/a |
25 | chr17:18305305-18305355 | SK-N-MC | brain: | n/a |
26 | chr17:18380159-18380209 | AG09319 | gingival: | n/a |
27 | chr17:18430908-18430958 | HRCEpiC | kidney: | n/a |
28 | chr17:18428092-18428142 | HEK293 | kidney: | embryo |
29 | chr17:18429951-18430001 | HEEpiC | esophagus: | n/a |
30 | chr17:18475978-18476028 | HMEC | breast: | n/a |
31 | chr17:18380159-18380209 | GM12892 | blood: | n/a |
32 | chr17:18295431-18295481 | HRE | kidney: | n/a |
33 | chr17:18378879-18378929 | HUVEC | blood vessel: | n/a |
34 | chr17:18397849-18397899 | H1-hESC | embryonic stem cell: | embryo |
35 | chr17:18324790-18324840 | Hepatocyte | liver: | n/a |
36 | chr17:18305305-18305355 | MCF-7 | breast: | n/a |
37 | chr17:18429951-18430001 | K562 | blood: | n/a |
38 | chr17:18421335-18421385 | HPAEpiC | pulmonary alveolar: | n/a |
39 | chr17:18295503-18295553 | CMK | blood: | n/a |
40 | chr17:18476059-18476109 | BJ | skin: | n/a |
41 | chr17:18313048-18313098 | HEEpiC | esophagus: | n/a |
42 | chr17:18378879-18378929 | MCF-7 | breast: | n/a |
43 | chr17:18295503-18295553 | HAEpiC | amniotic membrane: | n/a |
44 | chr17:18379129-18379179 | MCF-7 | breast: | n/a |
45 | chr17:18430908-18430958 | SK-N-SH | brain: | n/a |
46 | chr17:18476059-18476109 | GM19239 | blood: | n/a |
47 | chr17:18380159-18380209 | HCM | heart: | n/a |
48 | chr17:18476310-18476360 | RPTEC | kidney: | n/a |
49 | chr17:18430908-18430958 | ECC-1 | luminal epithelium: | n/a |
50 | chr17:18324790-18324840 | GM19239 | blood: | n/a |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FAM106A-2 | chr17:18427120-18427191 | ENSG00000273018.1 |
2 | lnc-FAM106A-2 | chr17:18420696-18420787 | ENSG00000273018.1 |
3 | lnc-AL353997.5.1-1 | chr17:18328108-18328411 | ENSG00000205266.5 |
4 | lnc-FAM106A-2 | chr17:18431900-18432061 | ENSG00000273018.1 |
5 | lnc-FAM106A-2 | chr17:18430884-18431074 | ENSG00000273018.1 |
6 | lnc-FAM106A-2 | chr17:18422796-18422988 | ENSG00000273018.1 |
7 | lnc-FAM106A-2 | chr17:18422796-18422988 | ENSG00000273018.1 |
8 | lnc-FAM106A-2 | chr17:18444241-18444277 | NONHSAT146384 |
9 | lnc-FAM106A-2 | chr17:18431887-18432061 | ENSG00000273018.1 |
10 | lnc-FAM106A-2 | chr17:18427091-18427191 | ENSG00000273018.1 |
11 | lnc-FAM106A-2 | chr17:18420604-18420787 | NONHSAT146381 |
12 | lnc-AL353997.5.1-2 | chr17:18317468-18317702 | XLOC_012131 |
13 | lnc-FAM106A-2 | chr17:18422796-18422988 | ENSG00000273018.1 |
14 | lnc-FAM106A-2 | chr17:18454820-18455008 | ENSG00000273018.1 |
15 | lnc-FAM106A-2 | chr17:18422796-18422988 | ENSG00000273018.1 |
16 | lnc-AL353997.5.1-1 | chr17:18327635-18327951 | ENSG00000205266.5 |
17 | lnc-FAM106A-2 | chr17:18426379-18426609 | NONHSAT146382 |
18 | lnc-FAM106A-2 | chr17:18420696-18420787 | ENSG00000273018.1 |
19 | lnc-FAM106A-2 | chr17:18431887-18432061 | ENSG00000273018.1 |
20 | lnc-FAM106A-2 | chr17:18436661-18436852 | ENSG00000273018.1 |
21 | lnc-AL353997.5.1-2 | chr17:18315660-18315807 | XLOC_012131 |
22 | lnc-FAM106A-2 | chr17:18446987-18447029 | ENSG00000273018.1 |
23 | lnc-FAM106A-2 | chr17:18420696-18420787 | ENSG00000273018.1 |
24 | lnc-FAM106A-2 | chr17:18427091-18427711 | ENSG00000273018.1 |
25 | lnc-AL353997.5.1-4 | chr17:18344268-18344334 | NONHSAT146373 |
26 | lnc-FAM106A-2 | chr17:18422796-18422988 | NONHSAT146381 |
27 | lnc-FAM106A-2 | chr17:18422796-18422988 | ENSG00000273018.1 |
28 | lnc-AL353997.5.1-4 | chr17:18343740-18343831 | NONHSAT146373 |
29 | lnc-FAM106A-2 | chr17:18436661-18437376 | ENSG00000273018.1 |
30 | lnc-FAM106A-2 | chr17:18420633-18420787 | NONHSAT146382 |
31 | lnc-FAM106A-2 | chr17:18435820-18436192 | ENSG00000273018.1 |
32 | lnc-FAM106A-2 | chr17:18422796-18422988 | ENSG00000273018.1 |
33 | lnc-FAM106A-2 | chr17:18445402-18445501 | ENSG00000273018.1 |
34 | lnc-FAM106A-2 | chr17:18431887-18432061 | ENSG00000273018.1 |
35 | lnc-FAM106A-2 | chr17:18436395-18436705 | NONHSAT146384 |
36 | lnc-FAM106A-2 | chr17:18420696-18420787 | ENSG00000273018.1 |
37 | lnc-FAM106A-2 | chr17:18445402-18445501 | ENSG00000273018.1 |
38 | lnc-FAM106A-2 | chr17:18426965-18427191 | ENSG00000273018.1 |
39 | lnc-FAM106A-2 | chr17:18431887-18432298 | ENSG00000273018.1 |
40 | lnc-FAM106A-2 | chr17:18422796-18422988 | ENSG00000273018.1 |
41 | lnc-FAM106A-2 | chr17:18445402-18445501 | ENSG00000273018.1 |
42 | lnc-FAM106A-2 | chr17:18431887-18432061 | ENSG00000273018.1 |
43 | lnc-FAM106A-2 | chr17:18420696-18420787 | ENSG00000273018.1 |
44 | lnc-FAM106A-2 | chr17:18454820-18454999 | ENSG00000273018.1 |
45 | lnc-FAM106A-2 | chr17:18446183-18446301 | ENSG00000273018.1 |
46 | lnc-FAM106A-2 | chr17:18435820-18436348 | ENSG00000273018.1 |
47 | lnc-FAM106A-2 | chr17:18422796-18422988 | ENSG00000273018.1 |
48 | lnc-FAM106A-2 | chr17:18431887-18432126 | NONHSAT146381 |
49 | lnc-FAM106A-2 | chr17:18435820-18435911 | ENSG00000273018.1 |
50 | lnc-FAM106A-2 | chr17:18435820-18435911 | ENSG00000273018.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000205266 | TF binding region |
USP32P2 | TF binding region |
ENSG00000267492 | TF binding region |
KRT16P1 | TF binding region |
ENSG00000267441 | TF binding region |
YWHAEP2 | TF binding region |
EVPLL | TF binding region |
KRT17P2 | TF binding region |
SRP68P2 | TF binding region |
NOS2P2 | TF binding region |
TBC1D3P4 | TF binding region |
ENSG00000264177 | TF binding region |
KRT16P4 | TF binding region |
LGALS9C | TF binding region |
ENSG00000227919 | TF binding region |
RN7SL639P | TF binding region |
TNPO1P2 | TF binding region |
ENSG00000240279 | TF binding region |
ENSG00000227077 | TF binding region |
FAM106A | TF binding region |
ENSG00000220161 | TF binding region |
CCDC144B | TF binding region |
ENSG00000273018 | TF binding region |
ENSG00000205266 | CpG island |
USP32P2 | CpG island |
ENSG00000267492 | CpG island |
KRT16P1 | CpG island |
ENSG00000267441 | CpG island |
YWHAEP2 | CpG island |
EVPLL | CpG island |
KRT17P2 | CpG island |
SRP68P2 | CpG island |
NOS2P2 | CpG island |
TBC1D3P4 | CpG island |
ENSG00000264177 | CpG island |
KRT16P4 | CpG island |
LGALS9C | CpG island |
ENSG00000227919 | CpG island |
RN7SL639P | CpG island |
TNPO1P2 | CpG island |
ENSG00000240279 | CpG island |
ENSG00000227077 | CpG island |
FAM106A | CpG island |
ENSG00000220161 | CpG island |
CCDC144B | CpG island |
ENSG00000273018 | CpG island |
ENSG00000263946 | chromatin interactions |
KIAA0528 | miRNA target sites |
KIAA0664 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs539709090 | chr17:18289049-18289050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs370721037 | chr17:18289127-18289128 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs181503829 | chr17:18289173-18289174 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs186698218 | chr17:18289175-18289176 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs535451698 | chr17:18289182-18289183 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs148435527 | chr17:18289187-18289188 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs2925934 | chr17:18289188-18289189 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs575291053 | chr17:18289196-18289197 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs1682278 | chr17:18289201-18289202 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs1682279 | chr17:18289207-18289208 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs1682280 | chr17:18289210-18289211 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs564093915 | chr17:18289217-18289218 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs577755304 | chr17:18289226-18289227 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs111468137 | chr17:18289243-18289244 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs78985911 | chr17:18289248-18289249 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs540085358 | chr17:18289250-18289251 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs560465558 | chr17:18289288-18289289 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs529245598 | chr17:18289289-18289290 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs191081697 | chr17:18289336-18289337 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
20 | rs562471508 | chr17:18289341-18289342 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
21 | rs142579339 | chr17:18289363-18289364 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
22 | rs151086884 | chr17:18289396-18289397 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs11870681 | chr17:18289461-18289462 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs373644655 | chr17:18289497-18289498 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs144875887 | chr17:18289498-18289499 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs571287937 | chr17:18289500-18289501 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs540001322 | chr17:18289581-18289582 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
28 | rs546833573 | chr17:18289583-18289584 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
29 | rs566811559 | chr17:18289599-18289600 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
30 | rs545290110 | chr17:18289613-18289614 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
31 | rs147041835 | chr17:18289615-18289616 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
32 | rs555293161 | chr17:18289648-18289649 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
33 | rs569251446 | chr17:18289700-18289701 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs148033503 | chr17:18289734-18289735 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs200274082 | chr17:18289744-18289745 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs11295053 | chr17:18289747-18289748 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs180977837 | chr17:18289761-18289762 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs578073255 | chr17:18289817-18289818 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs540413986 | chr17:18289834-18289835 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs554019902 | chr17:18289851-18289852 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs573936705 | chr17:18289883-18289884 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs542966155 | chr17:18289919-18289920 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs7222009 | chr17:18289923-18289924 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
44 | rs141503181 | chr17:18289935-18289936 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs34778621 | chr17:18289948-18289949 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs7222951 | chr17:18289949-18289950 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs7221741 | chr17:18289956-18289957 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs546747520 | chr17:18290034-18290035 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs185801515 | chr17:18290056-18290057 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs372308533 | chr17:18290076-18290077 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Breast cancer | 17603634 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Smith-Magenis syndrome | 18923513 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22492990 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 18414209 | CNVD |
Developmental delay | 21549014 | CNVD |
Epilepsy | 20970697 | CNVD |
Mental retardation | 18414209 | CNVD |
Mental retardation | 21549014 | CNVD |
Smith-Magenis syndrome | 21981782 | CNVD |
Smith-Magenis syndrome | 20188345 | CNVD |
Smith-Magenis syndrome | 16775514 | CNVD |
Smith-Magenis syndrome | 22585170 | CNVD |
Smith-Magenis syndrome | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Potocki-Lupski syndrome | 21271655 | CNVD |
Potocki-lupski syndrome | 17357070 | CNVD |
Potocki-lupski syndrome | 20110824 | CNVD |
Potocki-lupski syndrome | 18923514 | CNVD |
Potocki-lupski syndrome | 22241247 | CNVD |
Potocki-lupski syndrome | 20188345 | CNVD |
Schizophrenia | 21399695 | CNVD |
Mental retardation | 16773131 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Charcot-marie-tooth disease | 22470819 | CNVD |
Neurofibromatosis | 22470819 | CNVD |
Neuropathy | 22470819 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Smith-Magenis syndrome | 17357070 | CNVD |
Smith-Magenis syndrome | 18469339 | CNVD |
Smith-Magenis syndrome | 22241097 | CNVD |
Smith-Magenis syndrome | 22470819 | CNVD |
Tourette syndrome | 18923514 | CNVD |
Type 1 diabetes | 22470819 | CNVD |
Potocki-lupski syndrome | 18469339 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Neuropathy | 17597781 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Smith-Magenis syndrome | 17597781 | CNVD |
Potocki-lupski syndrome | 18059269 | CNVD |
Potocki-lupski syndrome | 17597781 | CNVD |
Mental retardation | 17847001 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 20409316 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Autism | 22543975 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Recurrent pregnancy loss | 19789632 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Autism | 21865298 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 19212409 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:18283800-18289400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
2 | chr17:18287800-18290000 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
3 | chr17:18289400-18289600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr17:18290800-18291400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr17:18291600-18292200 | Enhancers | Primary monocytes fromperipheralblood | blood |
6 | chr17:18291600-18292200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
7 | chr17:18291600-18292200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr17:18291600-18292600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
9 | chr17:18291800-18292000 | Enhancers | Primary mononuclear cells fromperipheralblood | Blood |
10 | chr17:18291800-18292200 | Enhancers | Primary B cells from peripheral blood | blood |
11 | chr17:18291800-18292200 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
12 | chr17:18291800-18293600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
13 | chr17:18292200-18292600 | Weak transcription | Primary T helper memory cells from peripheral blood 2 | blood |
14 | chr17:18292200-18294400 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
15 | chr17:18292600-18293200 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
16 | chr17:18292600-18293400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr17:18293000-18293400 | Enhancers | Primary T helper cells fromperipheralblood | blood |
18 | chr17:18293400-18293600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
19 | chr17:18293400-18293600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
20 | chr17:18293400-18293600 | Enhancers | Fetal Muscle Trunk | muscle |
21 | chr17:18294400-18294600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
22 | chr17:18306600-18306800 | Enhancers | GM12878-XiMat | blood |
23 | chr17:18306800-18314200 | Weak transcription | GM12878-XiMat | blood |
24 | chr17:18307600-18308000 | Enhancers | Primary B cells from peripheral blood | blood |
25 | chr17:18308000-18312400 | Weak transcription | Primary B cells from peripheral blood | blood |
26 | chr17:18311600-18312800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
27 | chr17:18312000-18312200 | Enhancers | Fetal Thymus | thymus |
28 | chr17:18312200-18312400 | Enhancers | Primary hematopoietic stem cells | blood |
29 | chr17:18312200-18312400 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
30 | chr17:18312200-18312400 | Enhancers | Primary T cells effector/memory enriched fromperipheralblood | blood |
31 | chr17:18312200-18312400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
32 | chr17:18312200-18312400 | Enhancers | Brain Cingulate Gyrus | brain |
33 | chr17:18312200-18312600 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
34 | chr17:18312200-18312600 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
35 | chr17:18312200-18312600 | Active TSS | Fetal Brain Female | brain |
36 | chr17:18312200-18312600 | Flanking Active TSS | Fetal Thymus | thymus |
37 | chr17:18312200-18312800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
38 | chr17:18312200-18312800 | Enhancers | Fetal Lung | lung |
39 | chr17:18312200-18313000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
40 | chr17:18312200-18313000 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
41 | chr17:18312200-18313000 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
42 | chr17:18312200-18313000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
43 | chr17:18312200-18313200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
44 | chr17:18312200-18313200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
45 | chr17:18312200-18313200 | Enhancers | Primary T helper cells fromperipheralblood | blood |
46 | chr17:18312200-18313200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
47 | chr17:18312200-18313200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
48 | chr17:18312200-18313200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
49 | chr17:18312200-18313400 | Enhancers | Primary monocytes fromperipheralblood | blood |
50 | chr17:18312200-18313600 | Enhancers | A549 | lung |